Cutaneous neuropathological features in Parkinson's disease and multiple system atrophy

Key Points

• Unique cutaneous neuropathological features distinguish Parkinson's disease from multiple system atrophy, highlighting differences in neurodegeneration.
• Key evidence identified distinct neural changes within skin samples, supporting the potential of cutaneous neuropathy as a biomarker.
• Assessment of skin biopsies revealed significant changes in nerve fibers, emphasizing the need to explore these as diagnostic tools.
• Findings suggest that identifying cutaneous features may enhance diagnostic accuracy for neurodegenerative disorders in clinical settings.